Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy
Koch-Weser, J.; Sidel, V.W.; Federman, E.B.; Kanarek, P.; Finer, D.C.; Eaton, A.E.
Annals of Internal Medicine 72(6): 857-868
1970
ISSN/ISBN: 0003-4819 PMID: 5448745 Document Number: 30142
Document emailed within 1 workday
Related Documents
Navaneethan, K. 1983: A study of the effects of cause specific death rates on age-specific death rates with special reference to Tamil Nadu Iips Newsletter 24(4): 12-20Navaneethan, K. 1983: A study of the effects of cause specific death rates on age-specific death rates with special reference to Tamil Nadu Iips Newsletter 24(4): 12-20
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Ortega-García, Mía.Pilar.; Abril-López de Medrano, V.; Gimeno-Cardona, Cón. 2016: Changes in the dosing of colistimethate sodium in critically ill patients Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 29(1): 53-54
Adler, S.; Segel, D.P. 1971: Nonoliguric renal failure secondary to sodium colistimethate: a report of four cases American Journal of the Medical Sciences 262(2): 109-114
Elferink, F.; van der Vijgh, W.J.; Klein, I.; Pinedo, H.M. 1986: Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding Clinical Chemistry 32(4): 641-645
Makeeva, V.L. 1978: Neurologic adverse manifestations and complications of ambulatory therapy with psychotropic drugs in the late stages Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 78(2): 178-182
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Glass, D.; Roffe, L.; Maini, R.N.; Wraith, D.G.; Nuki, G. 1975: Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity Clinical and Experimental Immunology 20(1): 55-63
Kruszewski, J.; Zaraś, E. 1994: Effect of cetirizine therapy on the rate of adverse reactions to specific desensitization Polski Tygodnik Lekarski 49(14-15): 337-340
Herman, Z.S.; Brus, R. 1978: Chemical agents exerting specific adverse effects on neurons synthesizing biogenic amines Postepy Higieny i Medycyny Doswiadczalnej 32(1): 79-115
Friis, B.; Thomsen, J. 1979: Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin Ugeskrift for Laeger 141(29): 1968-1972
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Cleator, I.G. 1983: Adverse effects of ranitidine therapy Canadian Medical Association Journal 129(5): 405
Gossius, G. 1986: Adverse effects in trimethoprim therapy Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(2): 147-149
Ramachandran, S. 1973: Adverse effects of emetine therapy Ceylon Medical Journal 18(3): 138-143
Halparin, L.S. 1984: Adverse effects of ranitidine therapy Canadian Medical Association Journal 130(6): 668; 672